LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Pharmacologic Class Indexing
- Class set ID
- aea76527-9c67-4153-90bc-3bdc9fcbd2a5
- Version
- 1
- Effective date
- 20230404
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use PLUVICTO safely and effectively. See full prescribing information for PLUVICTO. PLUVICTO ® (lutetium Lu 177 vipivotide tetraxetan) injection, for intravenous use Initial U.S. Approval: 2022 | Novartis Pharmaceuticals Corporation | 20260407 | 3 |